Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Pet Medication Market by Type (Antibiotics, Antifungal, Flea Products), By Application (Cat, Dog, Horse, Fish, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Pet Medication Market by Type (Antibiotics, Antifungal, Flea Products), By Application (Cat, Dog, Horse, Fish, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 138156 3300 Pharma & Healthcare 377 234 Pages 4.9 (43)

Market Overview:

The global pet medication market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing trend of pet ownership, rising awareness about animal health, and growing demand for premium quality pet medications. The global pet medication market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into antibiotics, antifungal products, flea products, and other products. The antibiotics segment accounted for a major share of the global pet medication market in 2017 and is projected to grow at a CAGR of 6% during the forecast period from 2018 to 2030. This growth can be attributed to an increase in bacterial infections among pets due to changing lifestyles and environmental conditions.

Global Pet Medication Industry Outlook

Product Definition:

Pet medication is any drug or other substance that is used to treat an illness, injury, or other medical condition in a pet. The most common types of pet medications are antibiotics, painkillers, and vaccines.


Antibiotics Market Size, Share & Trends Analysis Report By Product (Penicillin, Cephalosporin), By Application (Cancer/Inflammation, Infectious Disease), And Segment Forecasts, 2019 - 2026 -> The global antibiotics market size was valued at USD 25.5 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 2.7% from 2019 to 2026.


Antifungal is a medication used to treat fungal infections. The most common types of fungal infections include athlete's foot, ringworm, and jock itch. Antifungal medications are primarily used in the treatment of skin diseases but can also be used to treat some ear and eye infections as well as certain systemic (body-wide) fungal infections.

Application Insights:

The dog application segment led the global medication market in 2017. The pet dogs across the globe are becoming increasingly susceptible to a variety of diseases and disorders owing to unhealthy lifestyle, improper diet, unhygienic surroundings and lack of physical exercise. This trend is expected to drive demand for various pet medications over the forecast period.

In addition, rising awareness among people about companion animals and their health is anticipated to further propel growth over the coming years. In addition, increasing number of households having pets as a part-time job has also increased spending on vet care services which will boost industry growth further during this period. However due to rising cases of animal abandonment across countries such as India China etc., there has been a decline in adoption rates which will have an adverse impact on industry growth during this period but eventually turn around positive with time passing by.

Regional Analysis:

North America dominated the global pet medication market in 2017. This can be attributed to increasing pet ownership, high expenditure on veterinary care and rising awareness about animal health. According to a study published by the American Pet Products Association (APPA), in 2016, around 68% of U.S households owned at least one dog while 59% owned cats.

In Asia Pacific region, China accounted for the largest revenue share followed by Japan owing to rapid urbanization along with growing disposable income especially among middle-class population groups which includes corporate professionals as well as government employees who have enough time and money for pets but not necessarily a family member or children.

Growth Factors:

  • Increasing pet ownership: The global pet population is expected to grow at a CAGR of 3.8% from 2016 to 2020, reaching 862 million by 2020. This growth in the pet population is primarily attributed to the increase in urbanization and rising disposable incomes around the world.
  • Rising awareness about animal health and preventive care: There has been a rise in awareness among pet owners about animal health and preventive care in recent years, which has led to an increase in demand for pet medication products.
  • Technological advancements: The development of new technologies such as nanotechnology-based products is aiding the growth of the global Pet Medication market by providing innovative solutions for various diseases affecting pets.

Scope Of The Report

Report Attributes

Report Details

Report Title

Pet Medication Market Research Report

By Type

Antibiotics, Antifungal, Flea Products

By Application

Cat, Dog, Horse, Fish, Other

By Companies

Zoetis, Merck, Merial, Elanco, Bayer, Boehringer, Novartis, Virbac, Ceva, Vetoquinol, Nexvet, Aratana Therapeutics, Kindred Biosciences, Ambrx, Entest Biomedical, Taconic Biosciences

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Pet Medication Market Report Segments:

The global Pet Medication market is segmented on the basis of:


Antibiotics, Antifungal, Flea Products

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Cat, Dog, Horse, Fish, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Zoetis
  2. Merck
  3. Merial
  4. Elanco
  5. Bayer
  6. Boehringer
  7. Novartis
  8. Virbac
  9. Ceva
  10. Vetoquinol
  11. Nexvet
  12. Aratana Therapeutics
  13. Kindred Biosciences
  14. Ambrx
  15. Entest Biomedical
  16. Taconic Biosciences

Global Pet Medication Market Overview

Highlights of The Pet Medication Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Antibiotics
    2. Antifungal
    3. Flea Products
  1. By Application:

    1. Cat
    2. Dog
    3. Horse
    4. Fish
    5. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Pet Medication Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Pet Medication Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Pet medication is a term used to describe any type of medication that can be given to a pet. This includes both prescription and over-the-counter medications.

Some of the major companies in the pet medication market are Zoetis, Merck, Merial, Elanco, Bayer, Boehringer, Novartis, Virbac, Ceva, Vetoquinol, Nexvet, Aratana Therapeutics, Kindred Biosciences, Ambrx, Entest Biomedical, Taconic Biosciences.

The pet medication market is expected to register a CAGR of 5.8%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Pet Medication Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Pet Medication Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Pet Medication Market - Supply Chain
   4.5. Global Pet Medication Market Forecast
      4.5.1. Pet Medication Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Pet Medication Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Pet Medication Market Absolute $ Opportunity

5. Global Pet Medication Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Pet Medication Market Size and Volume Forecast by Type
      5.3.1. Antibiotics
      5.3.2. Antifungal
      5.3.3. Flea Products
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Pet Medication Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Pet Medication Market Size and Volume Forecast by Application
      6.3.1. Cat
      6.3.2. Dog
      6.3.3. Horse
      6.3.4. Fish
      6.3.5. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Pet Medication Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Pet Medication Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Pet Medication Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Pet Medication Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Pet Medication Demand Share Forecast, 2019-2029

9. North America Pet Medication Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Pet Medication Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Pet Medication Market Size and Volume Forecast by Application
      9.4.1. Cat
      9.4.2. Dog
      9.4.3. Horse
      9.4.4. Fish
      9.4.5. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Pet Medication Market Size and Volume Forecast by Type
      9.7.1. Antibiotics
      9.7.2. Antifungal
      9.7.3. Flea Products
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Pet Medication Demand Share Forecast, 2019-2029

10. Latin America Pet Medication Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Pet Medication Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Pet Medication Market Size and Volume Forecast by Application
      10.4.1. Cat
      10.4.2. Dog
      10.4.3. Horse
      10.4.4. Fish
      10.4.5. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Pet Medication Market Size and Volume Forecast by Type
      10.7.1. Antibiotics
      10.7.2. Antifungal
      10.7.3. Flea Products
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Pet Medication Demand Share Forecast, 2019-2029

11. Europe Pet Medication Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Pet Medication Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Pet Medication Market Size and Volume Forecast by Application
      11.4.1. Cat
      11.4.2. Dog
      11.4.3. Horse
      11.4.4. Fish
      11.4.5. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Pet Medication Market Size and Volume Forecast by Type
      11.7.1. Antibiotics
      11.7.2. Antifungal
      11.7.3. Flea Products
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Pet Medication Demand Share, 2019-2029

12. Asia Pacific Pet Medication Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Pet Medication Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Pet Medication Market Size and Volume Forecast by Application
      12.4.1. Cat
      12.4.2. Dog
      12.4.3. Horse
      12.4.4. Fish
      12.4.5. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Pet Medication Market Size and Volume Forecast by Type
      12.7.1. Antibiotics
      12.7.2. Antifungal
      12.7.3. Flea Products
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Pet Medication Demand Share, 2019-2029

13. Middle East & Africa Pet Medication Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Pet Medication Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Pet Medication Market Size and Volume Forecast by Application
      13.4.1. Cat
      13.4.2. Dog
      13.4.3. Horse
      13.4.4. Fish
      13.4.5. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Pet Medication Market Size and Volume Forecast by Type
      13.7.1. Antibiotics
      13.7.2. Antifungal
      13.7.3. Flea Products
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Pet Medication Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Pet Medication Market: Market Share Analysis
   14.2. Pet Medication Distributors and Customers
   14.3. Pet Medication Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Zoetis Overview Financials Developments Strategic Outlook
      14.4.2. Merck Overview Financials Developments Strategic Outlook
      14.4.3. Merial Overview Financials Developments Strategic Outlook
      14.4.4. Elanco Overview Financials Developments Strategic Outlook
      14.4.5. Bayer Overview Financials Developments Strategic Outlook
      14.4.6. Boehringer Overview Financials Developments Strategic Outlook
      14.4.7. Novartis Overview Financials Developments Strategic Outlook
      14.4.8. Virbac Overview Financials Developments Strategic Outlook
      14.4.9. Ceva Overview Financials Developments Strategic Outlook
      14.4.10. Vetoquinol Overview Financials Developments Strategic Outlook
      14.4.11. Nexvet Overview Financials Developments Strategic Outlook
      14.4.12. Aratana Therapeutics Overview Financials Developments Strategic Outlook
      14.4.13. Kindred Biosciences Overview Financials Developments Strategic Outlook
      14.4.14. Ambrx Overview Financials Developments Strategic Outlook
      14.4.15. Entest Biomedical Overview Financials Developments Strategic Outlook
      14.4.16. Taconic Biosciences Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us